MUSE stem cell therapy for traumatic brain injury study
Part of Brain & nervous system, Injuries & trauma clinical trials.
This study looks at the safety and outcomes of MUSE stem cell therapy for people with traumatic brain injury. If you have had a TBI at least 6 months ago and are planning to receive MUSE therapy outside the U.S., you may be able to join and help researchers learn more.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 6 and 75 years old.
- You must have had a traumatic brain injury at least 6 months ago.
- You must have chosen to get MUSE stem cell therapy at a licensed clinic outside the United States.
- You or your legal representative must be able to give permission for the study.
- You must be willing to have follow-up checks (in person or by phone/video) for up to 12 months.
- You must be able to share your medical records or treatment notes if available.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether stem cells taken from your own fat and given through an IV can help people with long-term brain damage from a head injury. It is for adults who have not gotten better with standard treatments.
This trial tests whether a single infusion of stem cells from donated umbilical cord tissue can help calm inflammation in the brain after severe traumatic brain injury. It is for patients aged 18–50 who need brain pressure monitoring and are not responding to verbal commands 5 days after sedation is stopped.
This study follows people who receive intranasal stem cell or exosome therapy (tiny packages from special cells) for brain or neurological conditions like stroke, brain injury, or cerebral palsy. Researchers track how well the treatment works by measuring inflammation markers in the blood and monitoring clinical improvements over time.
This Phase 2 study tests whether sildenafil (a medication better known for erectile function) can improve long-term symptoms and brain blood-flow issues after a past traumatic brain injury (TBI). It may help by improving blood vessel function in the brain and possibly reducing persistent post-concussion symptoms.
This trial studies whether brain stimulation through the scalp can improve cognitive (thinking and memory) training in people with chronic mild traumatic brain injury (TBI). Participants train on thinking tasks while receiving a targeted “control network neuromodulation” approach to see if it enhances training results.
This early study tests whether an intravenous (through a vein) stem cell treatment made from donated umbilical cord tissue is safe for people with traumatic brain injury. It focuses mainly on side effects and safety, and only includes participants who meet several health and pregnancy-related safety checks.
Hear when a new Traumatic Brain Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.